10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2009 | |||
Statement Of Income | |||
Period Ending Dec 31, 2009 10-K (Filed: Feb 26, 2010) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 29, 2007 | |
| Net revenues | $ 98,729 | 87,472 | 76,330 |
| Cost of revenues | 78,349 | 69,182 | 60,222 |
| Gross profit | 20,380 | 18,290 | 16,108 |
| Operating expenses | 13,942 | 12,244 | 11,314 |
| Operating profit | 6,438 | 6,046 | 4,794 |
| Interest expense, net | 525 | 509 | 435 |
| Income before income tax provision | 5,913 | 5,537 | 4,359 |
| Income tax provision | 2,205 | 2,193 | 1,722 |
| Income from continuing operations | 3,708 | 3,344 | 2,637 |
| Loss from discontinued operations, net of income tax benefit | (12) | (132) | 0 |
| Net income | 3,696 | 3,212 | 2,637 |
| Preference dividends, net of income tax benefit | 0 | 14 | 14 |
| Net income available to common shareholders | 3,696 | 3,198 | 2,623 |
| Basic earnings per common share: | |||
| Income from continuing operations | 2.59 | 2.32 | 1.97 |
| Loss from discontinued operations | (0.01) | (0.09) | 0.00 |
| Net income | 2.58 | 2.23 | 1.97 |
| Weighted average common shares outstanding | 1,434 | 1,434 | 1,328 |
| Diluted earnings per common share: | |||
| Income from continuing operations | 2.56 | 2.27 | 1.92 |
| Loss from discontinued operations | (0.01) | (0.09) | 0.00 |
| Net income | 2.55 | 2.18 | 1.92 |
| Weighted average common shares outstanding | 1,450 | 1,469 | 1,372 |
| Dividends declared per common share | 0.30 | 0.26 | 0.23 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2009 | |||
Statement Of Cash Flows Indirect | |||
Period Ending Dec 31, 2009 10-K (Filed: Feb 26, 2010) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 29, 2007 | |
| Cash flows from operating activities: | |||
| Cash receipts from revenues | $ 93,568 | 82,250 | 72,533 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (73,536) | (64,131) | (56,319) |
| Cash paid to other suppliers and employees | (13,121) | (11,832) | (10,769) |
| Interest and dividends received | 5 | 20 | 34 |
| Interest paid | (542) | (574) | (468) |
| Income taxes paid | (2,339) | (1,786) | (1,781) |
| Net cash provided by operating activities | 4,035 | 3,947 | 3,230 |
| Cash flows from investing activities: | |||
| Additions to property and equipment | (2,548) | (2,180) | (1,805) |
| Proceeds from sale-leaseback transactions | 1,562 | 204 | 601 |
| Acquisitions (net of cash acquired) and other investments | (101) | (2,651) | (1,984) |
| Purchase of short-term investments | (5) | 0 | 0 |
| Sale of short-term investments | 0 | 28 | 0 |
| Proceeds from sale or disposal of assets | 23 | 19 | 106 |
| Net cash used in investing activities | (1,069) | (4,580) | (3,082) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | (2,729) | 959 | 242 |
| Repayment of debt assumed in acquisition | 0 | (353) | 0 |
| Issuance of long-term debt | 2,800 | 350 | 6,000 |
| Repayments of long-term debt | (653) | (2) | (822) |
| Dividends paid | (439) | (383) | (323) |
| Derivative settlements | (3) | 0 | 0 |
| Proceeds from exercise of stock options | 250 | 328 | 553 |
| Excess tax benefits from stock-based compensation | 19 | 53 | 98 |
| Repurchase of common stock | (2,477) | (23) | (5,370) |
| Net cash provided by (used in) financing activities | (3,232) | 929 | 378 |
| Net increase (decrease) in cash and cash equivalents | (266) | 296 | 526 |
| Cash and cash equivalents at beginning of year | 1,352 | 1,056 | |
| Cash and cash equivalents at end of year | 1,086 | 1,352 | 1,056 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 3,696 | 3,212 | 2,637 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 1,389 | 1,274 | 1,095 |
| Stock-based compensation | 165 | 92 | 78 |
| Deferred income taxes and other non-cash items | 48 | (3) | 39 |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (86) | (291) | 280 |
| Inventories | (1,199) | (488) | (448) |
| Other current assets | 48 | 12 | (59) |
| Other assets | (2) | 19 | (26) |
| Accounts payable | 4 | (64) | (181) |
| Accrued expenses | (66) | 183 | (168) |
| Other long-term liabilities | 38 | 1 | (17) |
| Net cash provided by operating activities | 4,035 | 3,947 | 3,230 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CVS HEALTH CORP | ||
Ticker: CVS Fiscal Year: 2009 | ||
Statement Of Financial Position Classified | ||
Period Ending Dec 31, 2009 10-K (Filed: Feb 26, 2010) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2009 | Dec 31, 2008 | |
| Assets: | ||
| Cash and cash equivalents | $ 1,086 | 1,352 |
| Short-term investments | 5 | 0 |
| Accounts receivable, net | 5,457 | 5,384 |
| Inventories | 10,343 | 9,153 |
| Deferred income taxes | 506 | 435 |
| Other current assets | 140 | 202 |
| Total current assets | 17,537 | 16,526 |
| Property and equipment, net | 7,923 | 8,125 |
| Goodwill | 25,680 | 25,494 |
| Intangible assets, net | 10,127 | 10,446 |
| Other assets | 374 | 369 |
| Total assets | 61,641 | 60,960 |
| Liabilities: | ||
| Accounts payable | 3,560 | 3,801 |
| Claims and discounts payable | 3,075 | 2,814 |
| Accrued expenses | 3,246 | 3,178 |
| Short-term debt | 315 | 3,044 |
| Current portion of long-term debt | 2,104 | 653 |
| Total current liabilities | 12,300 | 13,490 |
| Long-term debt | 8,756 | 8,057 |
| Deferred income taxes | 3,678 | 3,702 |
| Other long-term liabilities | 1,102 | 1,137 |
| Commitments and contingencies (Note 12) | ||
| Redeemable noncontrolling interest | 37 | 0 |
| Shareholders' equity: | ||
| Common stock, par value $0.01: 3,200 shares authorized; 1,612 shares issued and 1,391 shares outstanding at December 31, 2009 and 1,603 shares issued and 1,436 shares outstanding at December 31, 2008 | 16 | 16 |
| Treasury stock, at cost: 219 shares at December 31, 2009 and 165 shares at December 31, 2008 | (7,610) | (5,812) |
| Shares held in trust: 2 shares at December 31, 2009 and 2008 | (56) | (56) |
| Capital surplus | 27,198 | 27,280 |
| Retained earnings | 16,355 | 13,098 |
| Accumulated other comprehensive loss | (135) | (143) |
| Total shareholders' equity | 35,768 | 34,574 |
| Total liabilities and shareholders' equity | 61,641 | 60,960 |
| Class of Stock | ||
| Preferred stock | ||
| Preferred stock | 0 | 0 |
| Preference stock, series one ESOP convertible | ||
| Preferred stock | 0 | 191 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |